How many insider trades does FilingIQ track for TVGN?

FilingIQ tracks 39 Form 4 insider transactions for TVGN (Tevogen Bio Holdings Inc.), covering filings from Feb 14, 2024 onwards. 3 of those were filed in the last 90 days.

Are TVGN insiders net buyers or net sellers?

Across the full Form 4 history for TVGN, 2 transactions (5%) were open-market purchases and 12 (31%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TVGN insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is TVGN in?

Tevogen Bio Holdings Inc. (TVGN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $20.93M.

TVGN insider trading

NasdaqGM Healthcare

Tevogen Bio Holdings Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

5% / 31%

Market cap

$20.93M

About Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920 which is in preclinical trial for treating cervical cancer; TVGN 960 which is in preclinical trial for treating oropharyngeal cancer; TVGN 601 which is in preclinical trial for treating multiple sclerosis; TVGN 930 which is in preclinical trial for treating Epstein-Barr virus associated lymphomas; and TVGN 116 a product candidate targeted at hepatitis B and is in preclinical trial. Tevogen Bio Holdings Inc. was formerly known as Tevogen Bio Inc. and changed its name to Tevogen Bio Holdings Inc. in February 2024. The company was founded in 2020 and is headquartered in Warren, New Jersey.

Company website: tevogen.com

TVGN insider activity at a glance

FilingIQ has scored 39 insider transactions for TVGN since Feb 14, 2024. The most recent filing in our index is dated Mar 13, 2026.

Across the full history, 2 open-market purchases and 12 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TVGN insider trades is 58.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live TVGN trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for TVGN?: FilingIQ tracks 39 Form 4 insider transactions for TVGN (Tevogen Bio Holdings Inc.), covering filings from Feb 14, 2024 onwards. 3 of those were filed in the last 90 days.
Are TVGN insiders net buyers or net sellers?: Across the full Form 4 history for TVGN, 2 transactions (5%) were open-market purchases and 12 (31%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TVGN insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is TVGN in?: Tevogen Bio Holdings Inc. (TVGN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $20.93M.

Methodology & sources

Every TVGN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.